Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Literature DB >> 17079308

Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.

Emmanuel J Wiertz¹, Robert Devlin, Helen L Collins, Maaike E Ressing.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2006 PMID： 17079308 PMCID： PMC1900142 DOI： 10.1128/JVI.01525-06

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

× No keyword cloud information.

91 in total

1. Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

Authors: Casper Paludan; Dorothee Schmid; Markus Landthaler; Martina Vockerodt; Dieter Kube; Thomas Tuschl; Christian Münz
Journal: Science Date: 2004-12-09 Impact factor: 47.728

2. Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection.

Authors: Maaike E Ressing; Sinéad E Keating; Daphne van Leeuwen; Danijela Koppers-Lalic; Isabel Y Pappworth; Emmanuel J H J Wiertz; Martin Rowe
Journal: J Immunol Date: 2005-06-01 Impact factor: 5.422

Review 3. Messenger RNA turnover and its regulation in herpesviral infection.

Authors: Britt A Glaunsinger; Donald E Ganem
Journal: Adv Virus Res Date: 2006 Impact factor: 9.937

4. The U(L)41 protein of herpes simplex virus 1 degrades RNA by endonucleolytic cleavage in absence of other cellular or viral proteins.

Authors: Brunella Taddeo; Weiran Zhang; Bernard Roizman
Journal: Proc Natl Acad Sci U S A Date: 2006-02-13 Impact factor: 11.205

5. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

Authors: Laila E Gamadia; Ester B M Remmerswaal; Jan F Weel; Frederieke Bemelman; René A W van Lier; Ineke J M Ten Berge
Journal: Blood Date: 2002-10-31 Impact factor: 22.113

6. Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion.

Authors: Martin Rowe; Britt Glaunsinger; Daphne van Leeuwen; Jianmin Zuo; David Sweetman; Don Ganem; Jaap Middeldorp; Emmanuel J H J Wiertz; Maaike E Ressing
Journal: Proc Natl Acad Sci U S A Date: 2007-02-21 Impact factor: 11.205

7. CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.

Authors: H M Long; T A Haigh; N H Gudgeon; A M Leen; C-W Tsang; J Brooks; E Landais; E Houssaint; S P Lee; A B Rickinson; G S Taylor
Journal: J Virol Date: 2005-04 Impact factor: 5.103

8. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

Authors: Dinesh Adhikary; Uta Behrends; Andreas Moosmann; Klaus Witter; Georg W Bornkamm; Josef Mautner
Journal: J Exp Med Date: 2006-03-20 Impact factor: 14.307

9. Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL.

Authors: Nagendra R Hegde; Claire Dunn; David M Lewinsohn; Michael A Jarvis; Jay A Nelson; David C Johnson
Journal: J Exp Med Date: 2005-10-10 Impact factor: 14.307

Review 10. Virus-specific CD4+ T cells: ready for direct attack.

Authors: Kevin N Heller; Cagan Gurer; Christian Münz
Journal: J Exp Med Date: 2006-03-20 Impact factor: 14.307

14 in total

1. Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors: L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal: J Virol Date: 2012-04-24 Impact factor: 5.103

2. Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels.

Authors: Andrew W Lee; Nan Wang; Tara M C Hornell; James J Harding; Chetan Deshpande; Laura Hertel; Vashti Lacaille; Achal Pashine; Claudia Macaubas; Edward S Mocarski; Elizabeth D Mellins
Journal: Mol Immunol Date: 2011-03-31 Impact factor: 4.407

3. Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.

Authors: Anabel S de la Garza-Rodea; Marieke C Verweij; Hester Boersma; Ietje van der Velde-van Dijke; Antoine A F de Vries; Rob C Hoeben; Dirk W van Bekkum; Emmanuel J H J Wiertz; Shoshan Knaän-Shanzer
Journal: PLoS One Date: 2011-01-06 Impact factor: 3.240

Review 10. Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.

Authors: Daniëlle Horst; Ruben J Geerdink; Anna M Gram; Arie J Stoppelenburg; Maaike E Ressing
Journal: Viruses Date: 2012-10-23 Impact factor: 5.048